Heng Mei
- Oncology top 2%
- Molecular Biology top 10%
- Immunology top 5%
- Infectious Diseases top 5%
- Hematology top 2%
- Co-authors
- Yu HuDanying LiaoPeter J. NewmanPanida LertkiatmongkolLu TangChenggong LiHuiwen JiangHuafang Wang
- Topics
- CAR-T cell therapy research (66 papers)Platelet Disorders and Treatments (18 papers)Immune Cell Function and Interaction (14 papers)
- Cited by
- HematologyOncologyInternal Medicine
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- ChinaUnited StatesChile
In The Last Decade
Heng Mei
151 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Oncology 1.1k
- Molecular Biology 807
- Immunology 557
- Infectious Diseases 471
- Hematology 435
Countries citing papers authored by Heng Mei
This map shows the geographic impact of Heng Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Mei more than expected).
Fields of papers citing papers by Heng Mei
This network shows the impact of papers produced by Heng Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Mei. The network helps show where Heng Mei may publish in the future.
Co-authorship network of co-authors of Heng Mei
This figure shows the co-authorship network connecting the top 25 collaborators of Heng Mei. A scholar is included among the top collaborators of Heng Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Mei. Heng Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 9 | |
| 5 | 13 | |
| 6 | 3 | |
| 7 | 0 | |
| 8 | 4 | |
| 9 | 0 | |
| 10 | 2 | |
| 11 | 10 | |
| 12 | 2 | |
| 13 | 9 | |
| 14 | 0 | |
| 15 | 3 | |
| 16 | 52 | |
| 17 | 50 | |
| 18 | 88 | |
| 19 | 64 | |
| 20 | 17 |
About Heng Mei
Heng Mei is a scholar working on Hematology, Oncology and Immunology, having authored 169 papers that have together received 2.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (66 papers), Platelet Disorders and Treatments (18 papers) and Immune Cell Function and Interaction (14 papers). The work is most often cited by research in Hematology (435 citations), Oncology (1.1k citations) and Internal Medicine (121 citations). Heng Mei has collaborated with scholars based in China, United States and Chile. Frequent co-authors include Yu Hu, Danying Liao, Peter J. Newman, Panida Lertkiatmongkol, Lu Tang, Chenggong Li, Huiwen Jiang, Huafang Wang, Jun Deng and Zhinan Yin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.